Mechanism of Action Glucagon-like peptide-1 (GLP-1) is a member of the incretin family (gastrointestinal hormones released after meals that increase insulin secretion during periods of hyperglycaemia)
However, TrumpRx may offer lower out-of-pocket options for individuals paying cash, thereby reducing reliance on employer coverage for some patients
The board of PolyPeptide unanimously recommended the offer, and its primary shareholder, Draupnir Holding, has committed its 55.65% stake
Age is a key factor
Many patients pursue treatment because they want to improve overall wellness, increase energy, move more comfortably, and feel better in their daily lives
Other peptides include: GIP (gastric inhibitory polypeptide) Also known as glucose-dependent insulinotropic polypeptide, which stimulates insulin secretion